

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | endothelium development (GO:0003158) | 6.86700133 |
| 2 | blood vessel maturation (GO:0001955) | 6.80266323 |
| 3 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 5.86664191 |
| 4 | wound healing, spreading of epidermal cells (GO:0035313) | 5.68707389 |
| 5 | endothelial tube morphogenesis (GO:0061154) | 5.26833968 |
| 6 | morphogenesis of an endothelium (GO:0003159) | 5.26833968 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 5.19973267 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.19973267 |
| 9 | endothelial cell morphogenesis (GO:0001886) | 5.05513843 |
| 10 | L-phenylalanine catabolic process (GO:0006559) | 5.04453182 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.04453182 |
| 12 | glyoxylate metabolic process (GO:0046487) | 4.89516553 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.62635048 |
| 14 | negative regulation of fibrinolysis (GO:0051918) | 4.57778058 |
| 15 | aromatic amino acid family catabolic process (GO:0009074) | 4.42025848 |
| 16 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.39824847 |
| 17 | glycine metabolic process (GO:0006544) | 4.36087032 |
| 18 | basement membrane organization (GO:0071711) | 4.33700184 |
| 19 | cell adhesion mediated by integrin (GO:0033627) | 4.32566504 |
| 20 | lysine metabolic process (GO:0006553) | 4.22795267 |
| 21 | lysine catabolic process (GO:0006554) | 4.22795267 |
| 22 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 4.19418317 |
| 23 | alpha-linolenic acid metabolic process (GO:0036109) | 4.14577780 |
| 24 | cysteine metabolic process (GO:0006534) | 4.12968465 |
| 25 | wound healing, spreading of cells (GO:0044319) | 4.11772495 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 4.09310602 |
| 27 | serine family amino acid catabolic process (GO:0009071) | 4.04270143 |
| 28 | regulation of fibrinolysis (GO:0051917) | 4.02553165 |
| 29 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 4.01403263 |
| 30 | axon extension involved in axon guidance (GO:0048846) | 4.01403263 |
| 31 | kynurenine metabolic process (GO:0070189) | 3.99292408 |
| 32 | tryptophan catabolic process (GO:0006569) | 3.87755824 |
| 33 | indole-containing compound catabolic process (GO:0042436) | 3.87755824 |
| 34 | indolalkylamine catabolic process (GO:0046218) | 3.87755824 |
| 35 | lymph vessel development (GO:0001945) | 3.85893775 |
| 36 | chondrocyte proliferation (GO:0035988) | 3.85593042 |
| 37 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.85100655 |
| 38 | high-density lipoprotein particle remodeling (GO:0034375) | 3.80586853 |
| 39 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.79990536 |
| 40 | protein carboxylation (GO:0018214) | 3.79990536 |
| 41 | bile acid biosynthetic process (GO:0006699) | 3.79761159 |
| 42 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 3.78307673 |
| 43 | regulation of protein activation cascade (GO:2000257) | 3.76128650 |
| 44 | negative regulation of chondrocyte differentiation (GO:0032331) | 3.74086048 |
| 45 | serine family amino acid metabolic process (GO:0009069) | 3.72470408 |
| 46 | serine family amino acid biosynthetic process (GO:0009070) | 3.72229680 |
| 47 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.72021707 |
| 48 | urea cycle (GO:0000050) | 3.69509447 |
| 49 | urea metabolic process (GO:0019627) | 3.69509447 |
| 50 | negative regulation of endothelial cell migration (GO:0010596) | 3.69284302 |
| 51 | homocysteine metabolic process (GO:0050667) | 3.68709914 |
| 52 | tryptophan metabolic process (GO:0006568) | 3.66829135 |
| 53 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.65234496 |
| 54 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.62603129 |
| 55 | semaphorin-plexin signaling pathway (GO:0071526) | 3.61777834 |
| 56 | protein maturation by protein folding (GO:0022417) | 3.60690563 |
| 57 | amino-acid betaine metabolic process (GO:0006577) | 3.59248607 |
| 58 | Golgi transport vesicle coating (GO:0048200) | 3.57964102 |
| 59 | COPI coating of Golgi vesicle (GO:0048205) | 3.57964102 |
| 60 | complement activation, alternative pathway (GO:0006957) | 3.55058013 |
| 61 | regulation of complement activation (GO:0030449) | 3.54081864 |
| 62 | endothelial cell differentiation (GO:0045446) | 3.52815245 |
| 63 | aldehyde catabolic process (GO:0046185) | 3.51238014 |
| 64 | angiogenesis involved in wound healing (GO:0060055) | 3.51027245 |
| 65 | negative regulation of sterol transport (GO:0032372) | 3.50301707 |
| 66 | negative regulation of cholesterol transport (GO:0032375) | 3.50301707 |
| 67 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.50187876 |
| 68 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.50187876 |
| 69 | regulation of triglyceride catabolic process (GO:0010896) | 3.45258445 |
| 70 | triglyceride homeostasis (GO:0070328) | 3.45184285 |
| 71 | acylglycerol homeostasis (GO:0055090) | 3.45184285 |
| 72 | endodermal cell differentiation (GO:0035987) | 3.42436837 |
| 73 | alpha-amino acid catabolic process (GO:1901606) | 3.40703703 |
| 74 | reverse cholesterol transport (GO:0043691) | 3.40312221 |
| 75 | arginine metabolic process (GO:0006525) | 3.38678577 |
| 76 | nitrogen cycle metabolic process (GO:0071941) | 3.37045650 |
| 77 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 3.35466034 |
| 78 | regulation of cholesterol esterification (GO:0010872) | 3.35148132 |
| 79 | regulation of endothelial cell differentiation (GO:0045601) | 3.31576872 |
| 80 | substrate-dependent cell migration (GO:0006929) | 3.30697755 |
| 81 | positive regulation of receptor recycling (GO:0001921) | 3.30607556 |
| 82 | negative regulation of focal adhesion assembly (GO:0051895) | 3.27311831 |
| 83 | negative regulation of cell junction assembly (GO:1901889) | 3.27311831 |
| 84 | negative regulation of adherens junction organization (GO:1903392) | 3.27311831 |
| 85 | bile acid metabolic process (GO:0008206) | 3.24721826 |
| 86 | aromatic amino acid family metabolic process (GO:0009072) | 3.23871234 |
| 87 | blood vessel endothelial cell migration (GO:0043534) | 3.23104077 |
| 88 | ganglion development (GO:0061548) | 3.22137408 |
| 89 | regulation of cholesterol homeostasis (GO:2000188) | 3.21677502 |
| 90 | paraxial mesoderm development (GO:0048339) | 3.21615262 |
| 91 | plasma lipoprotein particle clearance (GO:0034381) | 3.21017715 |
| 92 | protein-lipid complex remodeling (GO:0034368) | 3.20795735 |
| 93 | macromolecular complex remodeling (GO:0034367) | 3.20795735 |
| 94 | plasma lipoprotein particle remodeling (GO:0034369) | 3.20795735 |
| 95 | cell-substrate junction assembly (GO:0007044) | 3.20397662 |
| 96 | regulation of blood vessel endothelial cell migration (GO:0043535) | 3.20299282 |
| 97 | bile acid and bile salt transport (GO:0015721) | 3.20169440 |
| 98 | artery development (GO:0060840) | 3.20019855 |
| 99 | ethanol oxidation (GO:0006069) | 3.19757549 |
| 100 | imidazole-containing compound metabolic process (GO:0052803) | 3.15947190 |
| 101 | cellular amino acid catabolic process (GO:0009063) | 3.14037398 |
| 102 | endothelial cell proliferation (GO:0001935) | 3.12180849 |
| 103 | sprouting angiogenesis (GO:0002040) | 3.11278018 |
| 104 | heme transport (GO:0015886) | 3.10883094 |
| 105 | heart trabecula formation (GO:0060347) | 3.09637189 |
| 106 | drug catabolic process (GO:0042737) | 3.09002418 |
| 107 | surfactant homeostasis (GO:0043129) | 3.06032824 |
| 108 | phospholipid efflux (GO:0033700) | 3.05401412 |
| 109 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.04995588 |
| 110 | protein retention in ER lumen (GO:0006621) | 3.02581535 |
| 111 | hemidesmosome assembly (GO:0031581) | 3.01321385 |
| 112 | cellular modified amino acid catabolic process (GO:0042219) | 3.00003750 |
| 113 | apoptotic cell clearance (GO:0043277) | 2.99948202 |
| 114 | renal filtration (GO:0097205) | 2.99394333 |
| 115 | tyrosine metabolic process (GO:0006570) | 2.97028068 |
| 116 | cellular ketone body metabolic process (GO:0046950) | 2.96596332 |
| 117 | fibrinolysis (GO:0042730) | 2.96568835 |
| 118 | cell migration involved in heart development (GO:0060973) | 2.96530797 |
| 119 | urate metabolic process (GO:0046415) | 2.96328626 |
| 120 | positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862) | 2.92665133 |
| 121 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.92572088 |
| 122 | aspartate family amino acid catabolic process (GO:0009068) | 2.92390229 |
| 123 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.92375020 |
| 124 | negative regulation of cartilage development (GO:0061037) | 2.91486132 |
| 125 | drug metabolic process (GO:0017144) | 2.90791208 |
| 126 | embryonic heart tube development (GO:0035050) | 2.90737421 |
| 127 | regulation of endothelial cell migration (GO:0010594) | 2.90308973 |
| 128 | vasculogenesis (GO:0001570) | 2.89592269 |
| 129 | adherens junction assembly (GO:0034333) | 2.88005589 |
| 130 | protein localization to endosome (GO:0036010) | 2.87785456 |
| 131 | negative regulation of epithelial cell migration (GO:0010633) | 2.87670478 |
| 132 | cholesterol homeostasis (GO:0042632) | 2.86539611 |
| 133 | folic acid metabolic process (GO:0046655) | 2.86293353 |
| 134 | glomerular filtration (GO:0003094) | 2.85647337 |
| 135 | plasma lipoprotein particle assembly (GO:0034377) | 2.84502424 |
| 136 | carnitine metabolic process (GO:0009437) | 2.83991118 |
| 137 | midgut development (GO:0007494) | 2.83698639 |
| 138 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.83336997 |
| 139 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.82871501 |
| 140 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.82754413 |
| 141 | acetyl-CoA metabolic process (GO:0006084) | 2.81805919 |
| 142 | regulation of glomerular filtration (GO:0003093) | 2.81174927 |
| 143 | cellular glucuronidation (GO:0052695) | 2.80962281 |
| 144 | sterol homeostasis (GO:0055092) | 2.80919446 |
| 145 | regulation of cardioblast differentiation (GO:0051890) | 2.80548239 |
| 146 | 2-oxoglutarate metabolic process (GO:0006103) | 2.80170704 |
| 147 | positive regulation of endothelial cell migration (GO:0010595) | 2.79963006 |
| 148 | L-serine metabolic process (GO:0006563) | 2.78768126 |
| 149 | negative regulation of cell fate specification (GO:0009996) | 2.78251101 |
| 150 | barbed-end actin filament capping (GO:0051016) | 2.77496710 |
| 151 | one-carbon metabolic process (GO:0006730) | 2.76354014 |
| 152 | arginine catabolic process (GO:0006527) | 2.75911259 |
| 153 | Notch signaling involved in heart development (GO:0061314) | 2.75253241 |
| 154 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.74904514 |
| 155 | lipoprotein metabolic process (GO:0042157) | 2.74319263 |
| 156 | organic acid catabolic process (GO:0016054) | 2.73773533 |
| 157 | carboxylic acid catabolic process (GO:0046395) | 2.73773533 |
| 158 | tetrahydrofolate metabolic process (GO:0046653) | 2.73063526 |
| 159 | fatty acid beta-oxidation (GO:0006635) | 2.72008062 |
| 160 | epoxygenase P450 pathway (GO:0019373) | 2.71134854 |
| 161 | patterning of blood vessels (GO:0001569) | 2.70435701 |
| 162 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.70401375 |
| 163 | response to nitrosative stress (GO:0051409) | 2.70280352 |
| 164 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 2.69318055 |
| 165 | venous blood vessel morphogenesis (GO:0048845) | 2.69135819 |
| 166 | regulation of plasminogen activation (GO:0010755) | 2.69007082 |
| 167 | embryonic foregut morphogenesis (GO:0048617) | 2.68776467 |
| 168 | gap junction assembly (GO:0016264) | 2.67972890 |
| 169 | atrioventricular valve morphogenesis (GO:0003181) | 2.67101990 |
| 170 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.66898568 |
| 171 | benzene-containing compound metabolic process (GO:0042537) | 2.66796655 |
| 172 | glomerular visceral epithelial cell development (GO:0072015) | 2.66558444 |
| 173 | exogenous drug catabolic process (GO:0042738) | 2.65107014 |
| 174 | angiogenesis (GO:0001525) | 2.64638239 |
| 175 | flavonoid metabolic process (GO:0009812) | 2.64464801 |
| 176 | valine metabolic process (GO:0006573) | 2.64324278 |
| 177 | negative regulation of anoikis (GO:2000811) | 2.64068090 |
| 178 | 4-hydroxyproline metabolic process (GO:0019471) | 2.64042664 |
| 179 | glutamate metabolic process (GO:0006536) | 2.63855622 |
| 180 | lymphangiogenesis (GO:0001946) | 2.63724111 |
| 181 | positive regulation of cartilage development (GO:0061036) | 2.62413928 |
| 182 | endothelial cell chemotaxis (GO:0035767) | 2.62294284 |
| 183 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.57621961 |
| 184 | epithelial cell-cell adhesion (GO:0090136) | 2.56607931 |
| 185 | regulation of chondrocyte differentiation (GO:0032330) | 2.55979565 |
| 186 | glomerular basement membrane development (GO:0032836) | 2.54652631 |
| 187 | positive regulation of chondrocyte differentiation (GO:0032332) | 2.53753668 |
| 188 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.52599996 |
| 189 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.52090051 |
| 190 | positive regulation of epithelial cell migration (GO:0010634) | 2.49465143 |
| 191 | blood vessel remodeling (GO:0001974) | 2.49041479 |
| 192 | regulation of epithelial cell migration (GO:0010632) | 2.48418816 |
| 193 | endothelial cell migration (GO:0043542) | 2.48404197 |
| 194 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.47155693 |
| 195 | facial nerve structural organization (GO:0021612) | 2.47049021 |
| 196 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.47000244 |
| 197 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.46579733 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.57707278 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.37009386 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.35992895 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.04501305 |
| 5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.48692182 |
| 6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.25108773 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.22467145 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.13315047 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.08812922 |
| 10 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.91926132 |
| 11 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.91293355 |
| 12 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.87629568 |
| 13 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.56204479 |
| 14 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.51660789 |
| 15 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.43245748 |
| 16 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.26221219 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.23250462 |
| 18 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.07316771 |
| 19 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.97635616 |
| 20 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.92304796 |
| 21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.91716263 |
| 22 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.90224141 |
| 23 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.89028678 |
| 24 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.88494745 |
| 25 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.88071204 |
| 26 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.84655009 |
| 27 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.79970519 |
| 28 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.78600665 |
| 29 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.78493824 |
| 30 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.75548583 |
| 31 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.75499728 |
| 32 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.74435872 |
| 33 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.73571244 |
| 34 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.72531867 |
| 35 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.71256662 |
| 36 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.70485796 |
| 37 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.67768661 |
| 38 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.66635903 |
| 39 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.63394295 |
| 40 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.63114005 |
| 41 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.60849673 |
| 42 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.59723857 |
| 43 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.59365720 |
| 44 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.57448557 |
| 45 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.56439379 |
| 46 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.52940659 |
| 47 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.51905473 |
| 48 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.48429875 |
| 49 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.48271832 |
| 50 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.45490568 |
| 51 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.45125057 |
| 52 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.44795260 |
| 53 | KDM2B_26808549_Chip-Seq_K562_Human | 1.43103106 |
| 54 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.42946326 |
| 55 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.41738121 |
| 56 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.41694555 |
| 57 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.40372808 |
| 58 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.40372808 |
| 59 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.39429051 |
| 60 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.37487728 |
| 61 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37082722 |
| 62 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.36996903 |
| 63 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.36786797 |
| 64 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.36722691 |
| 65 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.36171640 |
| 66 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.33912955 |
| 67 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33229509 |
| 68 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.32029465 |
| 69 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.31810991 |
| 70 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.30544961 |
| 71 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.30174604 |
| 72 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.30174604 |
| 73 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.30174604 |
| 74 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.29752567 |
| 75 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.29663058 |
| 76 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.29090283 |
| 77 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.28202052 |
| 78 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.27265613 |
| 79 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.26803622 |
| 80 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.24965741 |
| 81 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.20467765 |
| 82 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.20081666 |
| 83 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.18115963 |
| 84 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.17340896 |
| 85 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.16443423 |
| 86 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.16193676 |
| 87 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.14642476 |
| 88 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.14441568 |
| 89 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.14356407 |
| 90 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.13590844 |
| 91 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.12289363 |
| 92 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.12285574 |
| 93 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11212554 |
| 94 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.10619740 |
| 95 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.09405589 |
| 96 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.09279924 |
| 97 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08014298 |
| 98 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.07939449 |
| 99 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.07453062 |
| 100 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.06974927 |
| 101 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.06822575 |
| 102 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.06096496 |
| 103 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.04479912 |
| 104 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.04140227 |
| 105 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.03525972 |
| 106 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.02823223 |
| 107 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.02559756 |
| 108 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.02559756 |
| 109 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01657709 |
| 110 | * TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.01631087 |
| 111 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.01096542 |
| 112 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.00741302 |
| 113 | ATF3_27146783_Chip-Seq_COLON_Human | 1.00261699 |
| 114 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.98767775 |
| 115 | * ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98424969 |
| 116 | MYC_22102868_ChIP-Seq_BL_Human | 0.96945300 |
| 117 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.96906967 |
| 118 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.96738927 |
| 119 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.96528700 |
| 120 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.95829119 |
| 121 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.94660763 |
| 122 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.94249236 |
| 123 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.94050579 |
| 124 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.93200840 |
| 125 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.92567638 |
| 126 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.92372174 |
| 127 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.90736305 |
| 128 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.90144478 |
| 129 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.89729937 |
| 130 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.88875658 |
| 131 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.88000221 |
| 132 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.87334863 |
| 133 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.86963878 |
| 134 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.86741055 |
| 135 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.86294535 |
| 136 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.86245695 |
| 137 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.85214983 |
| 138 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.84338847 |
| 139 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.83847857 |
| 140 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.83652247 |
| 141 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.82900912 |
| 142 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82618774 |
| 143 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.82604151 |
| 144 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.82407305 |
| 145 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.82240617 |
| 146 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.82010440 |
| 147 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81778399 |
| 148 | * SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.81110841 |
| 149 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.80814031 |
| 150 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.80116082 |
| 151 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 0.80000787 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.16875586 |
| 2 | MP0005360_urolithiasis | 5.53921792 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 3.98981092 |
| 4 | MP0005365_abnormal_bile_salt | 3.96825376 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.79450748 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.23928428 |
| 7 | MP0010368_abnormal_lymphatic_system | 2.52891308 |
| 8 | MP0003705_abnormal_hypodermis_morpholog | 2.45202639 |
| 9 | MP0000767_abnormal_smooth_muscle | 2.43297811 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.36320263 |
| 11 | MP0003252_abnormal_bile_duct | 2.34722923 |
| 12 | MP0005623_abnormal_meninges_morphology | 2.29169097 |
| 13 | MP0009840_abnormal_foam_cell | 2.24180813 |
| 14 | MP0005257_abnormal_intraocular_pressure | 2.19877177 |
| 15 | MP0002877_abnormal_melanocyte_morpholog | 2.18076388 |
| 16 | MP0005332_abnormal_amino_acid | 2.07086158 |
| 17 | MP0003828_pulmonary_edema | 2.03616615 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 1.98651202 |
| 19 | MP0009053_abnormal_anal_canal | 1.95144224 |
| 20 | MP0005083_abnormal_biliary_tract | 1.95065728 |
| 21 | MP0006138_congestive_heart_failure | 1.75556628 |
| 22 | MP0000751_myopathy | 1.75176939 |
| 23 | MP0001666_abnormal_nutrient_absorption | 1.73812935 |
| 24 | MP0005595_abnormal_vascular_smooth | 1.69987346 |
| 25 | MP0004019_abnormal_vitamin_homeostasis | 1.69864116 |
| 26 | MP0005409_darkened_coat_color | 1.64605970 |
| 27 | MP0004782_abnormal_surfactant_physiolog | 1.59478017 |
| 28 | MP0002295_abnormal_pulmonary_circulatio | 1.58080132 |
| 29 | MP0004272_abnormal_basement_membrane | 1.55748515 |
| 30 | MP0003091_abnormal_cell_migration | 1.53567889 |
| 31 | MP0004233_abnormal_muscle_weight | 1.51104026 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.49035624 |
| 33 | MP0004858_abnormal_nervous_system | 1.47492802 |
| 34 | MP0002249_abnormal_larynx_morphology | 1.45776823 |
| 35 | * MP0000609_abnormal_liver_physiology | 1.45646024 |
| 36 | MP0001614_abnormal_blood_vessel | 1.44567850 |
| 37 | MP0006054_spinal_hemorrhage | 1.42248096 |
| 38 | MP0008260_abnormal_autophagy | 1.41498581 |
| 39 | MP0003186_abnormal_redox_activity | 1.40943045 |
| 40 | MP0001879_abnormal_lymphatic_vessel | 1.39203522 |
| 41 | MP0000049_abnormal_middle_ear | 1.37256170 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.36114760 |
| 43 | * MP0005319_abnormal_enzyme/_coenzyme | 1.36039200 |
| 44 | MP0005058_abnormal_lysosome_morphology | 1.34741167 |
| 45 | * MP0010030_abnormal_orbit_morphology | 1.34667699 |
| 46 | MP0000537_abnormal_urethra_morphology | 1.32431523 |
| 47 | MP0002925_abnormal_cardiovascular_devel | 1.31608647 |
| 48 | MP0003195_calcinosis | 1.27981594 |
| 49 | MP0009643_abnormal_urine_homeostasis | 1.25082454 |
| 50 | MP0002127_abnormal_cardiovascular_syste | 1.20700047 |
| 51 | MP0004957_abnormal_blastocyst_morpholog | 1.19405554 |
| 52 | MP0002128_abnormal_blood_circulation | 1.18509263 |
| 53 | MP0008007_abnormal_cellular_replicative | 1.17805335 |
| 54 | MP0000598_abnormal_liver_morphology | 1.17297535 |
| 55 | MP0004133_heterotaxia | 1.16804379 |
| 56 | MP0004084_abnormal_cardiac_muscle | 1.16642453 |
| 57 | MP0002118_abnormal_lipid_homeostasis | 1.14425067 |
| 58 | MP0005367_renal/urinary_system_phenotyp | 1.11731579 |
| 59 | MP0000516_abnormal_urinary_system | 1.11731579 |
| 60 | MP0005330_cardiomyopathy | 1.10241691 |
| 61 | MP0000762_abnormal_tongue_morphology | 1.09491069 |
| 62 | MP0001958_emphysema | 1.07852740 |
| 63 | MP0009697_abnormal_copulation | 1.07490325 |
| 64 | MP0008438_abnormal_cutaneous_collagen | 1.05892403 |
| 65 | MP0005165_increased_susceptibility_to | 1.05072330 |
| 66 | MP0003890_abnormal_embryonic-extraembry | 1.04973863 |
| 67 | MP0005508_abnormal_skeleton_morphology | 1.04408258 |
| 68 | MP0002933_joint_inflammation | 1.03817064 |
| 69 | MP0000467_abnormal_esophagus_morphology | 1.02957320 |
| 70 | MP0003279_aneurysm | 1.02248406 |
| 71 | MP0010234_abnormal_vibrissa_follicle | 1.01456478 |
| 72 | MP0010352_gastrointestinal_tract_polyps | 1.01404837 |
| 73 | MP0003011_delayed_dark_adaptation | 0.99774795 |
| 74 | MP0003693_abnormal_embryo_hatching | 0.99553774 |
| 75 | MP0010630_abnormal_cardiac_muscle | 0.98970756 |
| 76 | MP0001764_abnormal_homeostasis | 0.98372300 |
| 77 | MP0006036_abnormal_mitochondrial_physio | 0.98081745 |
| 78 | MP0003935_abnormal_craniofacial_develop | 0.97772689 |
| 79 | MP0009384_cardiac_valve_regurgitation | 0.97175937 |
| 80 | MP0002092_abnormal_eye_morphology | 0.96887912 |
| 81 | MP0009672_abnormal_birth_weight | 0.96228186 |
| 82 | MP0000003_abnormal_adipose_tissue | 0.95149536 |
| 83 | MP0005197_abnormal_uvea_morphology | 0.94481395 |
| 84 | MP0009780_abnormal_chondrocyte_physiolo | 0.94289411 |
| 85 | MP0000249_abnormal_blood_vessel | 0.93193424 |
| 86 | MP0002896_abnormal_bone_mineralization | 0.93002395 |
| 87 | MP0005023_abnormal_wound_healing | 0.92843823 |
| 88 | MP0002282_abnormal_trachea_morphology | 0.91687268 |
| 89 | MP0003111_abnormal_nucleus_morphology | 0.91578017 |
| 90 | MP0001730_embryonic_growth_arrest | 0.91369220 |
| 91 | MP0003566_abnormal_cell_adhesion | 0.91230346 |
| 92 | MP0000678_abnormal_parathyroid_gland | 0.90170116 |
| 93 | MP0000343_altered_response_to | 0.89829236 |
| 94 | MP0004197_abnormal_fetal_growth/weight/ | 0.88583084 |
| 95 | MP0002088_abnormal_embryonic_growth/wei | 0.87071570 |
| 96 | MP0000266_abnormal_heart_morphology | 0.86434160 |
| 97 | MP0001915_intracranial_hemorrhage | 0.86395129 |
| 98 | MP0003984_embryonic_growth_retardation | 0.86229205 |
| 99 | MP0000749_muscle_degeneration | 0.85901612 |
| 100 | MP0003950_abnormal_plasma_membrane | 0.85083976 |
| 101 | MP0005380_embryogenesis_phenotype | 0.84398470 |
| 102 | MP0001672_abnormal_embryogenesis/_devel | 0.84398470 |
| 103 | MP0004043_abnormal_pH_regulation | 0.84299897 |
| 104 | MP0003119_abnormal_digestive_system | 0.83902192 |
| 105 | MP0005501_abnormal_skin_physiology | 0.83498314 |
| 106 | MP0000733_abnormal_muscle_development | 0.83247887 |
| 107 | MP0006035_abnormal_mitochondrial_morpho | 0.82752444 |
| 108 | MP0005248_abnormal_Harderian_gland | 0.80320677 |
| 109 | MP0003115_abnormal_respiratory_system | 0.79874822 |
| 110 | MP0002060_abnormal_skin_morphology | 0.79602101 |
| 111 | MP0002089_abnormal_postnatal_growth/wei | 0.79473562 |
| 112 | MP0001299_abnormal_eye_distance/ | 0.79221478 |
| 113 | MP0001756_abnormal_urination | 0.78397810 |
| 114 | MP0002972_abnormal_cardiac_muscle | 0.77439533 |
| 115 | MP0003567_abnormal_fetal_cardiomyocyte | 0.76459596 |
| 116 | MP0000566_synostosis | 0.75855876 |
| 117 | MP0000428_abnormal_craniofacial_morphol | 0.74932072 |
| 118 | MP0002111_abnormal_tail_morphology | 0.74729715 |
| 119 | MP0005670_abnormal_white_adipose | 0.74706961 |
| 120 | MP0003942_abnormal_urinary_system | 0.74313858 |
| 121 | MP0002086_abnormal_extraembryonic_tissu | 0.74048790 |
| 122 | MP0003077_abnormal_cell_cycle | 0.74025125 |
| 123 | MP0002254_reproductive_system_inflammat | 0.72954179 |
| 124 | MP0005503_abnormal_tendon_morphology | 0.72903761 |
| 125 | MP0003123_paternal_imprinting | 0.72635420 |
| 126 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.72481724 |
| 127 | MP0005167_abnormal_blood-brain_barrier | 0.72049812 |
| 128 | MP0005266_abnormal_metabolism | 0.71932279 |
| 129 | MP0004087_abnormal_muscle_fiber | 0.71494012 |
| 130 | MP0000750_abnormal_muscle_regeneration | 0.71441988 |
| 131 | MP0001544_abnormal_cardiovascular_syste | 0.71209393 |
| 132 | MP0005385_cardiovascular_system_phenoty | 0.71209393 |
| 133 | MP0003718_maternal_effect | 0.70999561 |
| 134 | * MP0002932_abnormal_joint_morphology | 0.70849192 |
| 135 | MP0009763_increased_sensitivity_to | 0.70605931 |
| 136 | MP0001697_abnormal_embryo_size | 0.70369916 |
| 137 | MP0002098_abnormal_vibrissa_morphology | 0.70340283 |
| 138 | MP0002084_abnormal_developmental_patter | 0.70319173 |
| 139 | MP0005451_abnormal_body_composition | 0.69942833 |
| 140 | MP0003385_abnormal_body_wall | 0.69606735 |
| 141 | MP0002796_impaired_skin_barrier | 0.68552028 |
| 142 | MP0001293_anophthalmia | 0.67503929 |
| 143 | MP0008932_abnormal_embryonic_tissue | 0.66632342 |
| 144 | MP0002108_abnormal_muscle_morphology | 0.64855299 |
| 145 | MP0005408_hypopigmentation | 0.64735844 |
| 146 | MP0005376_homeostasis/metabolism_phenot | 0.64314010 |
| 147 | MP0000462_abnormal_digestive_system | 0.64097124 |
| 148 | MP0005084_abnormal_gallbladder_morpholo | 0.63589697 |
| 149 | MP0005275_abnormal_skin_tensile | 0.63559721 |
| 150 | MP0003941_abnormal_skin_development | 0.63536738 |
| 151 | MP0002697_abnormal_eye_size | 0.62874250 |
| 152 | MP0002085_abnormal_embryonic_tissue | 0.62572946 |
| 153 | MP0005193_abnormal_anterior_eye | 0.62535985 |
| 154 | MP0001661_extended_life_span | 0.62365793 |
| 155 | MP0001849_ear_inflammation | 0.62167680 |
| 156 | MP0002233_abnormal_nose_morphology | 0.62060866 |
| 157 | MP0004036_abnormal_muscle_relaxation | 0.61418794 |
| 158 | MP0003315_abnormal_perineum_morphology | 0.61357269 |
| 159 | MP0004264_abnormal_extraembryonic_tissu | 0.60916642 |
| 160 | MP0008058_abnormal_DNA_repair | 0.60608864 |
| 161 | MP0000013_abnormal_adipose_tissue | 0.59842234 |
| 162 | MP0002080_prenatal_lethality | 0.59785541 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.55004407 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.13298331 |
| 3 | Premature rupture of membranes (HP:0001788) | 5.01721853 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 4.88089407 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.86828338 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 4.73551626 |
| 7 | Xanthomatosis (HP:0000991) | 4.41973168 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 3.98173617 |
| 9 | Cervical subluxation (HP:0003308) | 3.78691932 |
| 10 | Hypolipoproteinemia (HP:0010981) | 3.64162819 |
| 11 | Cerebral aneurysm (HP:0004944) | 3.63811315 |
| 12 | Hyperglycinuria (HP:0003108) | 3.61036626 |
| 13 | Hyperammonemia (HP:0001987) | 3.58263106 |
| 14 | Spinal rigidity (HP:0003306) | 3.58035851 |
| 15 | Wrist flexion contracture (HP:0001239) | 3.56979918 |
| 16 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.50750237 |
| 17 | Vascular tortuosity (HP:0004948) | 3.49455028 |
| 18 | Arterial tortuosity (HP:0005116) | 3.49076146 |
| 19 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.47918116 |
| 20 | Complement deficiency (HP:0004431) | 3.33541987 |
| 21 | Hyperlipoproteinemia (HP:0010980) | 3.26910589 |
| 22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.26089823 |
| 23 | Hypoglycemic coma (HP:0001325) | 3.25890920 |
| 24 | Skull defect (HP:0001362) | 3.24244533 |
| 25 | Hypercholesterolemia (HP:0003124) | 3.21148794 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.19648934 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.19648934 |
| 28 | Hyperglycinemia (HP:0002154) | 3.17352388 |
| 29 | Ketosis (HP:0001946) | 3.16683217 |
| 30 | Hematochezia (HP:0002573) | 3.13196186 |
| 31 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.12635259 |
| 32 | Shallow orbits (HP:0000586) | 3.12256017 |
| 33 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.08282602 |
| 34 | Hypoalphalipoproteinemia (HP:0003233) | 3.07123539 |
| 35 | Delayed CNS myelination (HP:0002188) | 3.00989598 |
| 36 | Abnormality of the intrinsic pathway (HP:0010989) | 2.99253117 |
| 37 | Vertebral compression fractures (HP:0002953) | 2.84255145 |
| 38 | Esophageal varix (HP:0002040) | 2.82975748 |
| 39 | Abnormality of the common coagulation pathway (HP:0010990) | 2.81957642 |
| 40 | Abnormality of methionine metabolism (HP:0010901) | 2.79564766 |
| 41 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.78856863 |
| 42 | Spastic diplegia (HP:0001264) | 2.76957612 |
| 43 | Short nail (HP:0001799) | 2.75062183 |
| 44 | Epidermoid cyst (HP:0200040) | 2.74941354 |
| 45 | Increased connective tissue (HP:0009025) | 2.72607861 |
| 46 | Aortic aneurysm (HP:0004942) | 2.70896095 |
| 47 | Aortic dissection (HP:0002647) | 2.68520924 |
| 48 | Late onset (HP:0003584) | 2.68163167 |
| 49 | Spontaneous hematomas (HP:0007420) | 2.66799308 |
| 50 | Abnormality of nucleobase metabolism (HP:0010932) | 2.66070033 |
| 51 | Abnormality of complement system (HP:0005339) | 2.63194152 |
| 52 | Bilateral microphthalmos (HP:0007633) | 2.58335402 |
| 53 | Difficulty climbing stairs (HP:0003551) | 2.57634636 |
| 54 | Joint hemorrhage (HP:0005261) | 2.57399654 |
| 55 | Wormian bones (HP:0002645) | 2.55403650 |
| 56 | Nonimmune hydrops fetalis (HP:0001790) | 2.53173977 |
| 57 | Fat malabsorption (HP:0002630) | 2.52502941 |
| 58 | Hepatocellular carcinoma (HP:0001402) | 2.49979596 |
| 59 | Hypochromic microcytic anemia (HP:0004840) | 2.49809688 |
| 60 | Dicarboxylic aciduria (HP:0003215) | 2.49332429 |
| 61 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.49332429 |
| 62 | Distal lower limb muscle weakness (HP:0009053) | 2.48453900 |
| 63 | Ketoacidosis (HP:0001993) | 2.46958732 |
| 64 | Abnormal cartilage morphology (HP:0002763) | 2.43033466 |
| 65 | Hyperbilirubinemia (HP:0002904) | 2.41220065 |
| 66 | Blue sclerae (HP:0000592) | 2.40888762 |
| 67 | Multiple enchondromatosis (HP:0005701) | 2.40210623 |
| 68 | Abnormality of the aortic arch (HP:0012303) | 2.38775574 |
| 69 | Disproportionate tall stature (HP:0001519) | 2.36659885 |
| 70 | Abnormality of the acetabulum (HP:0003170) | 2.35810254 |
| 71 | Atrophic scars (HP:0001075) | 2.33942711 |
| 72 | Malnutrition (HP:0004395) | 2.33569802 |
| 73 | Hemorrhage of the eye (HP:0011885) | 2.32947717 |
| 74 | Upper limb amyotrophy (HP:0009129) | 2.31324852 |
| 75 | Distal upper limb amyotrophy (HP:0007149) | 2.31324852 |
| 76 | Cerebral hemorrhage (HP:0001342) | 2.30660987 |
| 77 | Conjunctival telangiectasia (HP:0000524) | 2.29676897 |
| 78 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.29418619 |
| 79 | Lethargy (HP:0001254) | 2.28070025 |
| 80 | Proximal tubulopathy (HP:0000114) | 2.27853702 |
| 81 | Polycythemia (HP:0001901) | 2.27495691 |
| 82 | Abnormality of purine metabolism (HP:0004352) | 2.25145991 |
| 83 | Abnormal vertebral ossification (HP:0100569) | 2.24467820 |
| 84 | Gout (HP:0001997) | 2.24235970 |
| 85 | Flat acetabular roof (HP:0003180) | 2.22951081 |
| 86 | Visceral angiomatosis (HP:0100761) | 2.21838581 |
| 87 | Hemangiomatosis (HP:0007461) | 2.21533682 |
| 88 | Vertebral clefting (HP:0008428) | 2.20853887 |
| 89 | Nausea (HP:0002018) | 2.20416514 |
| 90 | Protrusio acetabuli (HP:0003179) | 2.19640581 |
| 91 | Bladder diverticulum (HP:0000015) | 2.18969294 |
| 92 | Mesangial abnormality (HP:0001966) | 2.18017776 |
| 93 | Lymphangioma (HP:0100764) | 2.17317685 |
| 94 | Mitral valve prolapse (HP:0001634) | 2.16622130 |
| 95 | Cerebral edema (HP:0002181) | 2.16345381 |
| 96 | Abnormality of dentin (HP:0010299) | 2.15449810 |
| 97 | Opisthotonus (HP:0002179) | 2.14700046 |
| 98 | Trismus (HP:0000211) | 2.14474156 |
| 99 | Abnormality of serum amino acid levels (HP:0003112) | 2.12920857 |
| 100 | Broad metatarsal (HP:0001783) | 2.11585986 |
| 101 | Ankle contracture (HP:0006466) | 2.09415010 |
| 102 | Ulnar bowing (HP:0003031) | 2.09382584 |
| 103 | Coxa vara (HP:0002812) | 2.08994917 |
| 104 | Broad face (HP:0000283) | 2.03483475 |
| 105 | Metabolic acidosis (HP:0001942) | 2.01955460 |
| 106 | Ankyloglossia (HP:0010296) | 2.00804076 |
| 107 | Increased variability in muscle fiber diameter (HP:0003557) | 1.99724185 |
| 108 | Vascular calcification (HP:0004934) | 1.99087947 |
| 109 | Back pain (HP:0003418) | 1.98853541 |
| 110 | Distal lower limb amyotrophy (HP:0008944) | 1.98346084 |
| 111 | Aortic valve stenosis (HP:0001650) | 1.97164878 |
| 112 | Soft skin (HP:0000977) | 1.96762166 |
| 113 | Joint stiffness (HP:0001387) | 1.96118707 |
| 114 | Vomiting (HP:0002013) | 1.95042273 |
| 115 | Joint laxity (HP:0001388) | 1.93875736 |
| 116 | Right ventricular cardiomyopathy (HP:0011663) | 1.93607417 |
| 117 | Neonatal onset (HP:0003623) | 1.93466522 |
| 118 | Ectopia lentis (HP:0001083) | 1.92233707 |
| 119 | Portal hypertension (HP:0001409) | 1.92211676 |
| 120 | Prominent metopic ridge (HP:0005487) | 1.92199693 |
| 121 | Skin nodule (HP:0200036) | 1.92173352 |
| 122 | Aneurysm (HP:0002617) | 1.91623276 |
| 123 | Venous insufficiency (HP:0005293) | 1.91590553 |
| 124 | Hydroureter (HP:0000072) | 1.91354907 |
| 125 | Cardiovascular calcification (HP:0011915) | 1.89179760 |
| 126 | Venous abnormality (HP:0002624) | 1.88656517 |
| 127 | Adactyly (HP:0009776) | 1.88316179 |
| 128 | Natal tooth (HP:0000695) | 1.87885241 |
| 129 | Hand muscle atrophy (HP:0009130) | 1.87217146 |
| 130 | Neonatal death (HP:0003811) | 1.86980503 |
| 131 | Abnormality of the metopic suture (HP:0005556) | 1.85848010 |
| 132 | Enlarged kidneys (HP:0000105) | 1.85661487 |
| 133 | Menorrhagia (HP:0000132) | 1.85007022 |
| 134 | Increased serum pyruvate (HP:0003542) | 1.82945032 |
| 135 | Abnormality of glycolysis (HP:0004366) | 1.82945032 |
| 136 | Stroke (HP:0001297) | 1.82550919 |
| 137 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.79578529 |
| 138 | Premature skin wrinkling (HP:0100678) | 1.78829177 |
| 139 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.78750364 |
| 140 | Hepatic necrosis (HP:0002605) | 1.78177553 |
| 141 | Hepatoblastoma (HP:0002884) | 1.78129508 |
| 142 | Abnormality of the nasal mucosa (HP:0000433) | 1.77744764 |
| 143 | Abnormality of carpal bone ossification (HP:0006257) | 1.77637151 |
| 144 | Rhabdomyolysis (HP:0003201) | 1.77535020 |
| 145 | Advanced eruption of teeth (HP:0006288) | 1.77424481 |
| 146 | Abnormality of the hepatic vasculature (HP:0006707) | 1.77304454 |
| 147 | Tetraparesis (HP:0002273) | 1.77053035 |
| 148 | Reticulocytosis (HP:0001923) | 1.76857894 |
| 149 | Abnormality of oral frenula (HP:0000190) | 1.75619361 |
| 150 | Generalized aminoaciduria (HP:0002909) | 1.75597748 |
| 151 | Oral leukoplakia (HP:0002745) | 1.75576969 |
| 152 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.74620472 |
| 153 | Fragile skin (HP:0001030) | 1.74334964 |
| 154 | Absent hand (HP:0004050) | 1.74311688 |
| 155 | Overgrowth (HP:0001548) | 1.73593025 |
| 156 | Steatorrhea (HP:0002570) | 1.73312547 |
| 157 | Limb-girdle muscle atrophy (HP:0003797) | 1.72490040 |
| 158 | Bronchomalacia (HP:0002780) | 1.72480667 |
| 159 | Myocardial infarction (HP:0001658) | 1.71894235 |
| 160 | Hypertriglyceridemia (HP:0002155) | 1.71509598 |
| 161 | Protruding ear (HP:0000411) | 1.70615566 |
| 162 | Hydroxyprolinuria (HP:0003080) | 1.70212903 |
| 163 | Abnormality of proline metabolism (HP:0010907) | 1.70212903 |
| 164 | Dilatation of the ascending aorta (HP:0005111) | 1.68948750 |
| 165 | Systemic lupus erythematosus (HP:0002725) | 1.68762835 |
| 166 | Mitral stenosis (HP:0001718) | 1.68216365 |
| 167 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.67327507 |
| 168 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.66577730 |
| 169 | Lumbar hyperlordosis (HP:0002938) | 1.66140784 |
| 170 | Mitral regurgitation (HP:0001653) | 1.65921581 |
| 171 | Congenital glaucoma (HP:0001087) | 1.65769686 |
| 172 | Macrocytic anemia (HP:0001972) | 1.64842953 |
| 173 | Abnormal ossification of hand bones (HP:0005921) | 1.64533120 |
| 174 | Cholelithiasis (HP:0001081) | 1.63678150 |
| 175 | Increased purine levels (HP:0004368) | 1.62794801 |
| 176 | Hyperuricemia (HP:0002149) | 1.62794801 |
| 177 | Conjugated hyperbilirubinemia (HP:0002908) | 1.61484006 |
| 178 | Selective tooth agenesis (HP:0001592) | 1.60295156 |
| 179 | Arachnodactyly (HP:0001166) | 1.59605050 |
| 180 | Ragged-red muscle fibers (HP:0003200) | 1.59404287 |
| 181 | Abnormality of urine glucose concentration (HP:0011016) | 1.59072684 |
| 182 | Glycosuria (HP:0003076) | 1.59072684 |
| 183 | Abnormality of iron homeostasis (HP:0011031) | 1.58734166 |
| 184 | Hip contracture (HP:0003273) | 1.58268205 |
| 185 | Abnormal gallbladder morphology (HP:0012437) | 1.57444194 |
| 186 | Myoglobinuria (HP:0002913) | 1.57327336 |
| 187 | Subcapsular cataract (HP:0000523) | 1.57139441 |
| 188 | Myotonia (HP:0002486) | 1.56364363 |
| 189 | Hyperacusis (HP:0010780) | 1.55998727 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 4.06188366 |
| 2 | BCKDK | 3.90603714 |
| 3 | TIE1 | 3.30055475 |
| 4 | TRIB3 | 3.25720029 |
| 5 | ERN1 | 2.74640819 |
| 6 | EPHB2 | 2.72830234 |
| 7 | BUB1 | 2.48670208 |
| 8 | PKN2 | 2.32863644 |
| 9 | PAK4 | 2.25699462 |
| 10 | TESK2 | 2.14342088 |
| 11 | NTRK1 | 2.12804828 |
| 12 | EPHA2 | 2.12133512 |
| 13 | TGFBR1 | 1.99197091 |
| 14 | NEK1 | 1.97461828 |
| 15 | SIK1 | 1.96854927 |
| 16 | MAP3K10 | 1.89244217 |
| 17 | PTK6 | 1.81730799 |
| 18 | FGFR4 | 1.76710006 |
| 19 | STK38L | 1.74158114 |
| 20 | SMG1 | 1.57488100 |
| 21 | PASK | 1.53477209 |
| 22 | TGFBR2 | 1.51675575 |
| 23 | LATS1 | 1.44292651 |
| 24 | TAOK2 | 1.41885409 |
| 25 | MAP3K11 | 1.38598273 |
| 26 | LATS2 | 1.34033799 |
| 27 | EPHB1 | 1.30837139 |
| 28 | WEE1 | 1.30731367 |
| 29 | TESK1 | 1.27460827 |
| 30 | NEK2 | 1.23795933 |
| 31 | WNK3 | 1.21095341 |
| 32 | RPS6KA4 | 1.18644301 |
| 33 | STK10 | 1.16549981 |
| 34 | PRKG2 | 1.15914560 |
| 35 | MAPK11 | 1.12550094 |
| 36 | TTN | 1.12318919 |
| 37 | ABL2 | 1.12317599 |
| 38 | FLT3 | 1.11815583 |
| 39 | MAP3K8 | 1.11104633 |
| 40 | EEF2K | 1.10314275 |
| 41 | LRRK2 | 1.09113963 |
| 42 | NME2 | 1.08673170 |
| 43 | EIF2AK1 | 1.06064939 |
| 44 | IRAK3 | 1.04142488 |
| 45 | MAP2K2 | 1.01602833 |
| 46 | ARAF | 0.99936344 |
| 47 | MAP3K3 | 0.99503786 |
| 48 | AURKA | 0.98826778 |
| 49 | LMTK2 | 0.97306425 |
| 50 | MAP2K3 | 0.97202165 |
| 51 | BRSK2 | 0.96174638 |
| 52 | TLK1 | 0.95970016 |
| 53 | MYLK | 0.95295292 |
| 54 | PTK2B | 0.94640305 |
| 55 | ERBB2 | 0.94312250 |
| 56 | PTK2 | 0.90578521 |
| 57 | AURKB | 0.89926352 |
| 58 | PRKD3 | 0.89851085 |
| 59 | CDK7 | 0.89486576 |
| 60 | ICK | 0.88614969 |
| 61 | TTK | 0.88280754 |
| 62 | CDK4 | 0.88231277 |
| 63 | FES | 0.87789353 |
| 64 | FGFR1 | 0.86822386 |
| 65 | PLK1 | 0.86074913 |
| 66 | PDGFRA | 0.84929525 |
| 67 | BRSK1 | 0.84205902 |
| 68 | ACVR1B | 0.84126927 |
| 69 | NEK9 | 0.83291968 |
| 70 | DYRK3 | 0.83203461 |
| 71 | ERBB4 | 0.82605513 |
| 72 | CDK6 | 0.80243988 |
| 73 | SRPK1 | 0.80020750 |
| 74 | MTOR | 0.79570029 |
| 75 | DYRK1B | 0.74145075 |
| 76 | RPS6KA2 | 0.72847053 |
| 77 | PLK4 | 0.71709212 |
| 78 | LIMK1 | 0.70798666 |
| 79 | RPS6KB2 | 0.70437278 |
| 80 | FER | 0.67137226 |
| 81 | PAK2 | 0.66140716 |
| 82 | MET | 0.64950031 |
| 83 | ROCK2 | 0.64534457 |
| 84 | ILK | 0.63932742 |
| 85 | STK4 | 0.63361212 |
| 86 | MST1R | 0.62557970 |
| 87 | MOS | 0.62394849 |
| 88 | DDR2 | 0.61139278 |
| 89 | RIPK1 | 0.58847287 |
| 90 | BMX | 0.58176292 |
| 91 | AKT2 | 0.57882334 |
| 92 | CDC7 | 0.57610964 |
| 93 | PBK | 0.55281123 |
| 94 | PDK2 | 0.54886054 |
| 95 | CDC42BPA | 0.54857359 |
| 96 | MAP3K6 | 0.54566289 |
| 97 | INSRR | 0.54495624 |
| 98 | DAPK3 | 0.53928801 |
| 99 | PAK1 | 0.50040100 |
| 100 | CSNK1A1L | 0.48617083 |
| 101 | CDK12 | 0.47813378 |
| 102 | PIK3CG | 0.47158550 |
| 103 | CDK8 | 0.47082941 |
| 104 | TSSK6 | 0.46281090 |
| 105 | CSNK1G3 | 0.45805378 |
| 106 | MKNK1 | 0.45684993 |
| 107 | DYRK2 | 0.45632249 |
| 108 | MAPKAPK3 | 0.45075366 |
| 109 | BRAF | 0.44686334 |
| 110 | CSNK1G1 | 0.44252182 |
| 111 | PRKCI | 0.42968241 |
| 112 | PRKD2 | 0.42405993 |
| 113 | PDGFRB | 0.41913695 |
| 114 | BCR | 0.41310609 |
| 115 | CSNK2A1 | 0.41224554 |
| 116 | MAP2K1 | 0.39797176 |
| 117 | DMPK | 0.39414011 |
| 118 | TYK2 | 0.38493042 |
| 119 | ATR | 0.38025982 |
| 120 | CHUK | 0.37443191 |
| 121 | KSR2 | 0.36645475 |
| 122 | CDK9 | 0.36572847 |
| 123 | PRKD1 | 0.36525882 |
| 124 | MELK | 0.36042050 |
| 125 | SRC | 0.35872821 |
| 126 | FRK | 0.35388918 |
| 127 | MARK2 | 0.34984714 |
| 128 | SCYL2 | 0.34834479 |
| 129 | ROCK1 | 0.34123644 |
| 130 | PLK3 | 0.33306424 |
| 131 | WNK4 | 0.32494274 |
| 132 | PIM2 | 0.32363872 |
| 133 | GSK3A | 0.31473233 |
| 134 | RPS6KC1 | 0.31085425 |
| 135 | RPS6KL1 | 0.31085425 |
| 136 | RPS6KA1 | 0.30605145 |
| 137 | PRKAA2 | 0.28537664 |
| 138 | TYRO3 | 0.27328940 |
| 139 | PAK6 | 0.25417718 |
| 140 | PDPK1 | 0.25246605 |
| 141 | DAPK1 | 0.23436339 |
| 142 | PRPF4B | 0.23120116 |
| 143 | MAP3K1 | 0.23066370 |
| 144 | EGFR | 0.21849092 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ECM-receptor interaction_Homo sapiens_hsa04512 | 3.43581048 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.27382211 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.95091723 |
| 4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.72102565 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.58183207 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.50705291 |
| 7 | * Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.49256002 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.43991097 |
| 9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.42563505 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.36348339 |
| 11 | Focal adhesion_Homo sapiens_hsa04510 | 2.29745487 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.27940292 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.27795945 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.22968073 |
| 15 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 2.19499487 |
| 16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.16521609 |
| 17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.14402249 |
| 18 | Adherens junction_Homo sapiens_hsa04520 | 2.07183412 |
| 19 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.98195613 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.91512378 |
| 21 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.91037756 |
| 22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.87808865 |
| 23 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.86744399 |
| 24 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.82173786 |
| 25 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.80786587 |
| 26 | Peroxisome_Homo sapiens_hsa04146 | 1.77029135 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.71737870 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.68499068 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.67442653 |
| 30 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.66914582 |
| 31 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.66446584 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.65811965 |
| 33 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.65120182 |
| 34 | Carbon metabolism_Homo sapiens_hsa01200 | 1.59710930 |
| 35 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.56339589 |
| 36 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.53634654 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.53480045 |
| 38 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.49747420 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.49230009 |
| 40 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.48972263 |
| 41 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.48949975 |
| 42 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.47122655 |
| 43 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.44388224 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.44224319 |
| 45 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.42892534 |
| 46 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.42069712 |
| 47 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.40655766 |
| 48 | Axon guidance_Homo sapiens_hsa04360 | 1.39732401 |
| 49 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.39062534 |
| 50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.37352108 |
| 51 | Other glycan degradation_Homo sapiens_hsa00511 | 1.37351768 |
| 52 | Proteasome_Homo sapiens_hsa03050 | 1.33467986 |
| 53 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.31987031 |
| 54 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.30243515 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.29056894 |
| 56 | Retinol metabolism_Homo sapiens_hsa00830 | 1.28331080 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 1.27293148 |
| 58 | Tight junction_Homo sapiens_hsa04530 | 1.26983852 |
| 59 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.25818334 |
| 60 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.25560262 |
| 61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.25464707 |
| 62 | Histidine metabolism_Homo sapiens_hsa00340 | 1.23841031 |
| 63 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.21863649 |
| 64 | Amoebiasis_Homo sapiens_hsa05146 | 1.18544661 |
| 65 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.18256736 |
| 66 | Bile secretion_Homo sapiens_hsa04976 | 1.16508501 |
| 67 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.15079372 |
| 68 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.13576145 |
| 69 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.12907696 |
| 70 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.12530088 |
| 71 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.11445394 |
| 72 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.10072750 |
| 73 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.07725358 |
| 74 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.05925734 |
| 75 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.99336893 |
| 76 | Ribosome_Homo sapiens_hsa03010 | 0.99091185 |
| 77 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.98712955 |
| 78 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.98080835 |
| 79 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.97759256 |
| 80 | Lysine degradation_Homo sapiens_hsa00310 | 0.96613772 |
| 81 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.95849914 |
| 82 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.94375676 |
| 83 | Pathways in cancer_Homo sapiens_hsa05200 | 0.92594761 |
| 84 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.91167040 |
| 85 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.90525990 |
| 86 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.89803668 |
| 87 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.89439959 |
| 88 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.89077419 |
| 89 | DNA replication_Homo sapiens_hsa03030 | 0.86820772 |
| 90 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.85623295 |
| 91 | Shigellosis_Homo sapiens_hsa05131 | 0.82943472 |
| 92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.79073006 |
| 93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.78963184 |
| 94 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.77951275 |
| 95 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.76712270 |
| 96 | Spliceosome_Homo sapiens_hsa03040 | 0.71864722 |
| 97 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.71708184 |
| 98 | Mismatch repair_Homo sapiens_hsa03430 | 0.70449867 |
| 99 | Lysosome_Homo sapiens_hsa04142 | 0.70297881 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.67883669 |
| 101 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.66941018 |
| 102 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.65900287 |
| 103 | ABC transporters_Homo sapiens_hsa02010 | 0.65666636 |
| 104 | Melanogenesis_Homo sapiens_hsa04916 | 0.64673768 |
| 105 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.62813668 |
| 106 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.62042922 |
| 107 | Gap junction_Homo sapiens_hsa04540 | 0.61458212 |
| 108 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.61420396 |
| 109 | RNA transport_Homo sapiens_hsa03013 | 0.58392108 |
| 110 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.58004457 |
| 111 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57721527 |
| 112 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.57274581 |
| 113 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.56074032 |
| 114 | Pertussis_Homo sapiens_hsa05133 | 0.55781471 |
| 115 | Galactose metabolism_Homo sapiens_hsa00052 | 0.55585841 |
| 116 | RNA polymerase_Homo sapiens_hsa03020 | 0.55359440 |
| 117 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.54400183 |
| 118 | Base excision repair_Homo sapiens_hsa03410 | 0.54160167 |
| 119 | Endocytosis_Homo sapiens_hsa04144 | 0.53432376 |
| 120 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.53211401 |
| 121 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.52238404 |
| 122 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.49455306 |
| 123 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.49386117 |
| 124 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48090100 |
| 125 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.46654834 |
| 126 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.45625853 |
| 127 | Colorectal cancer_Homo sapiens_hsa05210 | 0.44828520 |
| 128 | Salmonella infection_Homo sapiens_hsa05132 | 0.44749979 |
| 129 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44032696 |
| 130 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.39745749 |
| 131 | Bladder cancer_Homo sapiens_hsa05219 | 0.39392958 |
| 132 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.38673733 |
| 133 | Cell cycle_Homo sapiens_hsa04110 | 0.37612387 |
| 134 | Homologous recombination_Homo sapiens_hsa03440 | 0.37546746 |
| 135 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.33715420 |
| 136 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.32490258 |
| 137 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.32208875 |
| 138 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.32016539 |
| 139 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.31011027 |
| 140 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.30072296 |
| 141 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.29225970 |
| 142 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.28329160 |
| 143 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.24760341 |
| 144 | Insulin resistance_Homo sapiens_hsa04931 | 0.23409714 |
| 145 | Parkinsons disease_Homo sapiens_hsa05012 | 0.23362786 |
| 146 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.23209389 |
| 147 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.23167839 |
| 148 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.18790564 |
| 149 | Prion diseases_Homo sapiens_hsa05020 | 0.17384204 |
| 150 | Thyroid cancer_Homo sapiens_hsa05216 | 0.16973489 |
| 151 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.15420766 |
| 152 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.15213898 |
| 153 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.12500842 |

